Research progress in strategies to improve the efficacy and safety of doxorubicin for cancer chemotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Research progress in strategies to improve the efficacy and safety of doxorubicin for cancer chemotherapy
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 21, Issue 12, Pages 1385-1398
Publisher
Informa UK Limited
Online
2021-10-14
DOI
10.1080/14737140.2021.1991316
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulated cell death pathways in doxorubicin-induced cardiotoxicity
- (2021) Effimia Christidi et al. Cell Death & Disease
- Hybrid System for Local Drug Delivery and Magnetic Hyperthermia Based on SPIONs Loaded with Doxorubicin and Epirubicin
- (2021) Dorota Nieciecka et al. Pharmaceutics
- A novel Bcl-2 inhibitor, BM-1197, induces apoptosis in malignant lymphoma cells through the endogenous apoptotic pathway
- (2020) Yue-Li Sun et al. BMC CANCER
- Effects of doxorubicin‐induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: Insights for future interventions
- (2020) Nichanan Osataphan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Uncoupling DNA damage from chromatin damage to detoxify doxorubicin
- (2020) Xiaohang Qiao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right
- (2020) Duxin Sun et al. ACS Nano
- Nanocarrier-based Drug Delivery System for Cancer Therapeutics: A Review of the Last Decade
- (2020) Muhammad Sohail et al. CURRENT MEDICINAL CHEMISTRY
- One molecule two goals: A selective P-glycoprotein modulator increases drug transport across gastro-intestinal barrier and recovers doxorubicin toxicity in multidrug resistant cancer cells
- (2020) Marialessandra Contino et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Self-targeting visualizable hyaluronate nanogel for synchronized intracellular release of doxorubicin and cisplatin in combating multidrug-resistant breast cancer
- (2020) Wen Ma et al. Nano Research
- A fluorescence study of the loading and time stability of doxorubicin in sodium cholate/PEO-PPO-PEO triblock copolymer mixed micelles
- (2019) Elisamaria Tasca et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Magnetic nanoparticles for hyperthermia in cancer treatment: an emerging tool
- (2019) Jobin Jose et al. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
- Effects of doxorubicin on the heart: From molecular mechanisms to intervention strategies
- (2019) Nanthip Prathumsap et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the market
- (2019) Mara Gonçalves et al. JOURNAL OF CONTROLLED RELEASE
- Protective effects of curcumin against doxorubicin-induced toxicity and resistance: A review
- (2018) Mohammad Mohajeri et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Natural history of myocardial deformation in children, adolescents, and young adults exposed to anthracyclines: Systematic review and meta-analysis
- (2018) Mirela Tuzovic et al. ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES
- Toxicity of Doxorubicin (Dox) to different experimental organ systems
- (2018) Arivalagan Pugazhendhi et al. LIFE SCIENCES
- Nanoformulations of doxorubicin: how far have we come and where do we go from here?
- (2018) Ivana Borišev et al. NANOTECHNOLOGY
- Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
- (2018) Stefania Gorini et al. Oxidative Medicine and Cellular Longevity
- The Static Magnetic Field Remotely Boosts the Efficiency of Doxorubicin through Modulating ROS Behaviors
- (2018) Behnam Hajipour Verdom et al. Scientific Reports
- Long-Circulating Amphiphilic Doxorubicin for Tumor Mitochondria-Specific Targeting
- (2018) Jingchao Xi et al. ACS Applied Materials & Interfaces
- Advances in nano-delivery systems for doxorubicin: an updated insight
- (2017) Ummarah Kanwal et al. JOURNAL OF DRUG TARGETING
- NO and HNO donors, nitrones, and nitroxides: Past, present, and future
- (2017) Catarina Oliveira et al. MEDICINAL RESEARCH REVIEWS
- Evolution and clinical translation of drug delivery nanomaterials
- (2017) Shabir Hassan et al. Nano Today
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- A phase II study of a new formulation of nonpegylated liposomal doxorubicin (doxorubicin GP-pharm) as first-line treatment in patients with advanced soft-tissue sarcomas (STS) who are age 65 or older: A GEIS trial.
- (2017) A. Lopez-Pousa et al. JOURNAL OF CLINICAL ONCOLOGY
- Nanomedicines: From Bench to Bedside and Beyond
- (2016) Henry Havel et al. AAPS Journal
- HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician’s choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer
- (2016) Kathy Miller et al. BMC CANCER
- Molecularly imprinted polymers synthesized using reduction-cleavable hyperbranched polymers for doxorubicin hydrochloride with enhanced loading properties and controlled release
- (2016) Fangfang Chen et al. JOURNAL OF MATERIALS SCIENCE
- Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials
- (2016) Joseph M. Caster et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles
- (2015) Pengcheng Yu et al. Acta Biomaterialia
- Clinical Translation of Nanomedicine
- (2015) Yuanzeng Min et al. CHEMICAL REVIEWS
- First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma
- (2015) James R. Whittle et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Fitness Profiling Links Topoisomerase II Regulation of Centromeric Integrity to Doxorubicin Resistance in Fission Yeast
- (2015) Thi Thuy Trang Nguyen et al. Scientific Reports
- Nanopharmaceuticals (part 1): products on the market
- (2014) Volkmar Weissig et al. International Journal of Nanomedicine
- Thermosensitive liposomes with higher phase transition temperature for targeted drug delivery to tumor
- (2014) Jun Chen et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- NT-23 * PHASE 1/2A STUDY OF GLUTATHIONE PEGYLATED LIPOSOMAL DOXORUBICIN (2B3-101) IN BREAST CANCER PATIENTS WITH BRAIN METASTASES (BCBM) OR RECURRENT HIGH GRADE GLIOMAS (HGG)
- (2014) B. M. Kerklaan et al. NEURO-ONCOLOGY
- Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)
- (2014) Pieter J. Gaillard et al. PLoS One
- Anthracycline nano-delivery systems to overcome multiple drug resistance: A comprehensive review
- (2013) Ping Ma et al. Nano Today
- Therapeutic nanoparticles in clinics and under clinical evaluation
- (2013) Catherine A Schütz et al. Nanomedicine
- A tumor-targeting nano doxorubicin delivery system built from amphiphilic polyrotaxane-based block copolymers
- (2013) Lan Jiang et al. POLYMER
- Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
- (2013) Baoxu Pang et al. Nature Communications
- Inhibition of AMP-activated Protein Kinase α (AMPKα) by Doxorubicin Accentuates Genotoxic Stress and Cell Death in Mouse Embryonic Fibroblasts and Cardiomyocytes
- (2012) Shaobin Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
- (2012) Christoph Mamot et al. LANCET ONCOLOGY
- Treatment of doxorubicin-resistant MCF7/Dx cells with nitric oxide causes histone glutathionylation and reversal of drug resistance
- (2011) Anastasia de Luca et al. BIOCHEMICAL JOURNAL
- Lyso-thermosensitive liposomal doxorubicin: an adjuvant to increase the cure rate of radiofrequency ablation in liver cancer
- (2011) Ronnie TP Poon et al. Future Oncology
- Biotechnological doxorubicin production: pathway and regulation engineering of strains for enhanced production
- (2010) Narayan Prasad Niraula et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Improving the therapeutic index of anthracycline chemotherapy: Focus on liposomal doxorubicin (Myocet™)
- (2009) R.C.F. Leonard et al. BREAST
- Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer
- (2009) Ronnie TP Poon et al. EXPERT OPINION ON PHARMACOTHERAPY
- Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer
- (2009) Seymour INTERNATIONAL JOURNAL OF ONCOLOGY
- Nitrones as therapeutics
- (2008) Robert A. Floyd et al. FREE RADICAL BIOLOGY AND MEDICINE
- Fluorescence intensity and lifetime imaging of free and micellar-encapsulated doxorubicin in living cells
- (2008) Xiaowen Dai et al. Nanomedicine-Nanotechnology Biology and Medicine
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started